Sai Life Sciences Hits Record High; SEBI RA Finlight Research Sees Upside Potential Above ₹950

Published : Jul 30, 2025, 04:00 PM IST
https://stocktwits.com/news-articles/markets/equity/sai-life-sciences-hits-record-high-sebi-ra-finlight-research-sees-upside-potential-above-950/choQz5qR5zN

Synopsis

The analyst recommends a ‘buy on dips’ strategy at ₹800, citing export-led growth and strong fundamentals.

Sai Life Sciences is attracting investor attention with a major breakout on the charts and robust underlying fundamentals. The stock is currently trading at ₹847.35, after hitting an all-time high of ₹852.6 earlier on Wednesday.

Technically, the stock has recently broken out of a long consolidation zone, now trading above the ₹800 resistance-turned-support level, backed by strong volumes, noted SEBI-registered firm Finlight Research India.  

The price remains well above the key 20-day, 50-day, and 200-day simple moving averages (SMA). The relative strength index (RSI) is at around 68, reflecting continued strength without being in overbought territory. At the same time, the moving average convergence/divergence (MACD) remains positive with no signs of a bearish crossover.

Sai Life operates across drug discovery, preclinical services, process development, and commercial manufacturing. The company services over 280 global pharma and biotech firms, including 18 of the top 25 pharma giants worldwide.

Fundamentally, its revenue mix is diversified, with 43% of total revenue coming from early-stage drug discovery, and the remainder from contract development and manufacturing, Finlight Research said in a post.

With 97% of revenues from exports, the company enjoys insulation from domestic disruptions but remains exposed to currency fluctuations and global regulatory risks.

For traders, the stock remains a strong “buy on dips” candidate, the analyst said. Buying near the ₹800 retest level could offer favorable risk-reward with targets of ₹875, ₹900, and ₹950+ while a stop-loss can be placed at ₹775.

Retail sentiment on Stocktwits turned ‘extremely bullish’ from ‘neutral’ a day earlier, amid ‘high’ message volumes.

Year-to-date, the stock has gained around 13%

For updates and corrections, email newsroom[at]stocktwits[dot]com<

PREV

Stay updated with all the latest Business News, including market trends, Share Market News, stock updates, taxation, IPOs, banking, finance, real estate, savings, and investments. Track daily Gold Price changes, updates on DA Hike, and the latest developments on the 8th Pay Commission. Get in-depth analysis, expert opinions, and real-time updates to make informed financial decisions. Download the Asianet News Official App from the Android Play Store and iPhone App Store to stay ahead in business.

Read more Articles on

Recommended Stories

Could The Moon Make SpaceX The World’s First ‘$100 Trillion’ Company? Elon Musk Thinks So
Disc Medicine Stock Slides After FDA Fast-Track Approval Doubts Surface — Wall Street Calls It An ‘Overreaction’